Target intelligence / Profile preview

Microbial cell membrane and envelope

Molecular classification
Complex structural assembly, Lipid bilayer, Cell wall component
01

Overview

The microbial cell membrane and envelope represent the fundamental structural barriers of bacteria and fungi, providing protection against environmental stress and maintaining cellular homeostasis (Silhavy et al., 2010, Cold Spring Harb Perspect Biol). In bacteria, the envelope is composed of the inner cytoplasmic membrane and a peptidoglycan cell wall, while Gram-negative species also feature an asymmetric outer membrane (Kohanski et al., 2010, Nat Rev Microbiol). These structures are essential for viability, as they regulate osmotic pressure and house the machinery for nutrient uptake and protein secretion. Because the biochemical composition of these envelopes—such as peptidoglycan in bacteria and ergosterol in fungi—is distinct from mammalian cells, they are primary targets for many classes of antibiotics and antifungals (Odds et al., 2003, J Antimicrob Chemother). Drugs targeting the envelope work by either inhibiting the synthesis of its components, such as beta-lactams and glycopeptides, or by physically disrupting the membrane bilayer, as seen with polymyxins and daptomycin (Poirel et al., 2017, Clin Microbiol Rev).

Other names
Bacterial cell envelopeFungal cell wallCytoplasmic membraneOuter membranePlasma membranePeptidoglycan layer
02

Mechanism of action

Inhibition of peptidoglycan biosynthesis and cross-linking, disruption of cytoplasmic membrane integrity and potential, pore formation in the lipid bilayer, and inhibition of fungal cell wall components like beta-glucan.

03

Biological functions

Structural integrityOsmotic protectionSelective permeabilityNutrient transportCell divisionSignal transduction
04

Disease associations

Bacterial infectionFungal infectionSepsisAntimicrobial resistance
05

Safety considerations

NephrotoxicityNeurotoxicityInfusion-related reactionsMicrobiome dysbiosisSelection for multi-drug resistant organisms
06

Interacting drugs

Penicillin G

7 more in the full profile.

07

Biomarkers

Minimum Inhibitory Concentration (MIC)ProcalcitoninC-reactive proteinBacterial DNA load

Beyond the preview

Go deeper on Microbial cell membrane and envelope.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Microbial cell membrane and envelope.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call